Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1980 Jun;132(6):514–520.

Hepatoma.

PMCID: PMC1272145  PMID: 6250289

Full text

PDF
514

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Friedman M. A., Volberding P. A., Cassidy M. J., Resser K. J., Wasserman T. H., Phillips T. L. Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1885–1888. [PubMed] [Google Scholar]
  2. Johnson F. L., Lerner K. G., Siegel M., Feagler J. R., Majerus P. W., Hartmann J. R., Thomas E. D. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet. 1972 Dec 16;2(7790):1273–1276. doi: 10.1016/s0140-6736(72)92649-9. [DOI] [PubMed] [Google Scholar]
  3. Kelly J. K., Davies J. S., Jones A. W. Alpha-1-antitrypsin deficiency and hepatocellular carcinoma. J Clin Pathol. 1979 Apr;32(4):373–376. doi: 10.1136/jcp.32.4.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Larouze B., Saimot G., Lustbader E. D., London W. T., Werner B. G., Payet M. Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa. Lancet. 1976 Sep 11;2(7985):534–538. doi: 10.1016/s0140-6736(76)91792-x. [DOI] [PubMed] [Google Scholar]
  5. Lee Y. T. Systemic and regional treatment of primary carcinoma of the liver. Cancer Treat Rev. 1977 Sep;4(3):195–212. doi: 10.1016/s0305-7372(77)80024-8. [DOI] [PubMed] [Google Scholar]
  6. Margolis S., Homcy C. Systemic manifestations of hepatoma. Medicine (Baltimore) 1972 Sep;51(5):381–391. doi: 10.1097/00005792-197209000-00003. [DOI] [PubMed] [Google Scholar]
  7. Omata M., Ashcavai M., Liew C. T., Peters R. L. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens. Gastroenterology. 1979 Feb;76(2):279–287. [PubMed] [Google Scholar]
  8. Peers F. G., Linsell C. A. Dietary aflatoxins and liver cancer--a population based study in Kenya. Br J Cancer. 1973 Jun;27(6):473–484. doi: 10.1038/bjc.1973.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Peters R. L., Afroudakis A. P., Tatter D. The changing incidence of association of hepatitis B with hepatocellular carcinoma in California. Am J Clin Pathol. 1977 Jul;68(1):1–7. doi: 10.1093/ajcp/68.1.1. [DOI] [PubMed] [Google Scholar]
  10. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol. 1978;24:40–69. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES